TriMas (NASDAQ:TRS) Rating Lowered to “Hold” at Zacks Research

by · The Markets Daily

TriMas (NASDAQ:TRS – Get Free Report) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

Several other equities research analysts also recently commented on the stock. BWS Financial restated a “buy” rating and issued a $45.00 price target on shares of TriMas in a research report on Friday, December 5th. Wall Street Zen lowered TriMas from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. KeyCorp lowered their price target on TriMas from $45.00 to $38.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a research note on Monday. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $41.50.

View Our Latest Analysis on TriMas

TriMas Stock Performance

NASDAQ TRS opened at $33.91 on Thursday. The company has a quick ratio of 1.42, a current ratio of 2.68 and a debt-to-equity ratio of 0.56. TriMas has a 52-week low of $19.33 and a 52-week high of $40.34. The business’s 50-day moving average price is $34.67 and its 200 day moving average price is $33.78. The firm has a market cap of $1.38 billion, a P/E ratio of 31.40 and a beta of 0.62.

TriMas (NASDAQ:TRS – Get Free Report) last announced its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. TriMas had a return on equity of 12.39% and a net margin of 4.35%.The company had revenue of $269.26 million during the quarter, compared to analyst estimates of $262.05 million. During the same quarter in the previous year, the firm posted $0.43 EPS. The firm’s quarterly revenue was up 17.4% on a year-over-year basis. TriMas has set its FY 2025 guidance at 2.020-2.120 EPS. On average, equities research analysts expect that TriMas will post 1.69 earnings per share for the current year.

Insider Activity

In related news, Director Jeffrey A. Fielkow acquired 2,000 shares of the stock in a transaction dated Tuesday, November 11th. The shares were acquired at an average price of $31.46 per share, with a total value of $62,920.00. Following the acquisition, the director owned 17,653 shares in the company, valued at approximately $555,363.38. The trade was a 12.78% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 14.20% of the company’s stock.

Hedge Funds Weigh In On TriMas

Several large investors have recently added to or reduced their stakes in TRS. Mariner LLC lifted its position in shares of TriMas by 2.2% during the third quarter. Mariner LLC now owns 19,536 shares of the industrial products company’s stock worth $755,000 after purchasing an additional 414 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its position in TriMas by 8.1% in the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 8,693 shares of the industrial products company’s stock worth $336,000 after purchasing an additional 654 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in TriMas by 35.4% during the 2nd quarter. BNP Paribas Financial Markets now owns 3,319 shares of the industrial products company’s stock worth $95,000 after buying an additional 868 shares in the last quarter. Quarry LP bought a new position in TriMas in the 3rd quarter valued at $36,000. Finally, AE Wealth Management LLC increased its stake in shares of TriMas by 13.2% in the 3rd quarter. AE Wealth Management LLC now owns 8,408 shares of the industrial products company’s stock valued at $325,000 after buying an additional 982 shares during the period. Institutional investors and hedge funds own 99.42% of the company’s stock.

TriMas Company Profile

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Read More